Moreover, Van Loenhout et al. showed that adherent GBM cells were more sensitive to auranofin (AF), an inhibitor of antioxidant thioredoxin reductase, than the relevant cells cultured in neurospheres [46]. The gene discussed is PRDX5; the disease is glioblastoma.